Main Newsletter
Mastery Series
Therapy Series
 
Letter From The Editor

There are finally some guidelines coming from the Endocrine Society on treating obesity. This is significant because the guidelines signify the recognition of obesity as a disease to treat and not a problem that causes other diseases such as heart disease and diabetes. I believe that these new guidelines were brought about because of the expanding ways that we now have to treat the disease. Lapband and gastric bypass have both been hailed as a treatment for obesity but as we have seen over the past few years many people fail on these therapies over time because of a lack of education and support.

Now we another new method for these patients and you have to wonder if it will fair any better long term. The Maestro Rechargeable System works in a totally new way to cause weight loss.

It amazes me that once again we miss the psychological reasons for failure in treating obesity and provide little education, guidance or support for our patients to be successful. This is much the same problem that we have in diabetes. With over 5,000 certified diabetes educators in the United States, and the proven success in having CDE's work with diabetes patients, it's crazy that individual CDE's can't work with individual patients and get reimbursed for their services. Hopefully this will change as we realize the need for more help than pills or devices or surgery can give to our patients.

*****

Announcements:

dLifeTV.com: Sunday, January 25, 7PM ET

From dLife.com: "dLife looks at breaking insulin barriers in type 2 treatment with Dr. Steve Edelman. Plus, dLife explains most important number in your diabetes care – the A1C. And, how a pastor's wife started a movement in faith-based healthcare." Sundays live online at dLifeTV.com at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at dLifeTV.com
 
*****************************

We can make a difference!

*****************************

Dave Joffe, Editor-in-chiefRead More

Scroll down for items in the current newsletter

Newsflash

New Guidelines Released on Pharmacological Management of Obesity

See this week's Item #1.




Tool for your Practice

Diabetes Motion was founded in 2014 by Dr. Sheri Colberg, a leading expert on diabetes and exercise, to help people with diabetes exercise safely. The mission of Diabetes Motion is to provide practical guidance about blood glucose management to anyone who wants to be physically active with diabetes. Find out more with this informational PDF printout and then pass it on to all your patients: Diabetes Motion.

 




Product of the Week

The Maestro Rechargeable System is indicated for treatment of patients aged at least 18 years with a BMI of 35 to 45 with at least one obesity-related condition and who have failed to lose weight on a weight loss program. The novel device is the first to target the nerve pathway between the brain and stomach that controls hunger and satiety, according to a press release. See this week's Item #3.
 

  

Test Your Knowledge Question #765

Which of the following has been shown to correlate with CHD reduction?

a. Low HDL
b. Low LDL
c. High trigycerides

For the complete question and answer, just follow this link. 

 

Diabetes In Control Has Over 15000 Studies & Articles In Our Archives

Quote of the Week!

"Don't be afraid of missing opportunities. Behind every failure is an opportunity somebody wishes they had missed."
                                                                                           ...Lily Tomlin
 


Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?
CME/CE of the Week
Christine A. Kessler, RN, MN, CSANP

Category: Nutrition
Credits: .75



Advertisement


Search Articles On Diabetes In Control